IFNA1 and hepatitis C virus infection: The lack of induction of endogenous IFNs in the liver of chronic hepatitis C patients [6]–[9], or the proteolytic inactivation of signaling adaptor proteins in sensory pathways by HCV protease NS3/4A [10], add to the rationale of treating hepatitis C with IFN-based regimens.